Furthermore, given the discovery of the protein’s role in cancer progression, the inhibition of FABP4 might offer a viable therapeutic option for cancer patients through the suppression or decrease of early-stage tumors and metastasis, and they have a possible use as biomarkers for cancer detection [63,64,65,66,67,68]. The gene discussed is FABP4; the disease is cancer.